Size | Price | Stock | Qty |
---|---|---|---|
1mg |
|
||
5mg |
|
||
Other Sizes |
|
Purity: ≥98%
Fumonisin B1 (HSDB7077; RT-013063; HSDB-7077; RT013063) is a naturally occuring mycotoxin/fungal metabolite isolated from Fusarium moniliforme. It acs as a novel and potent inhibitor of sphingosine N-acyltransferase (ceramide synthase) which disrupts de novo sphingolipid biosynthesis.
Targets |
|
|
---|---|---|
ln Vitro |
In the kidney cells of monkeys, fumonisin B1 alters gene expression and signal transduction pathways [3]. In LLC-PK1 renal cells, fumonisin B1 enhances the first breakdown of sphingolipid metabolism and the build-up of sphingosine, leading to apoptotic DNA damage in rat astrocytes [3].
|
|
ln Vivo |
|
|
References |
[1]. Henry MH, et al. The toxicity of fumonisin B1, B2, and B3, individually and in combination, in chicken embryos. Poult Sci. 2001 Apr;80(4):401-7.
[2]. Shephard GS, et al. Disruption of sphingolipid metabolism in non-human primates consuming diets of fumonisin-containing Fusarium moniliforme culture material. Toxicon. 1996 May;34(5):527-34. [3]. Wang SK, et al. Effect of fumonisin B₁ on the cell cycle of normal human liver cells. Mol Med Rep. 2013 Jun;7(6):1970-6. |
Molecular Formula |
C34H59NO15
|
---|---|
Molecular Weight |
721.82996
|
CAS # |
116355-83-0
|
Related CAS # |
Fumonisin B1-13C34;1217458-62-2
|
SMILES |
CCCC[C@H]([C@H]([C@@H](OC(C[C@H](C(O)=O)CC(O)=O)=O)C[C@H](C[C@@H](CCCC[C@H](C[C@@H]([C@@H](N)C)O)O)O)C)OC(C[C@H](C(O)=O)CC(O)=O)=O)C
|
InChi Key |
UVBUBMSSQKOIBE-DSLOAKGESA-N
|
InChi Code |
InChI=1S/C34H59NO15/c1-5-6-9-20(3)32(50-31(44)17-23(34(47)48)15-29(41)42)27(49-30(43)16-22(33(45)46)14-28(39)40)13-19(2)12-24(36)10-7-8-11-25(37)18-26(38)21(4)35/h19-27,32,36-38H,5-18,35H2,1-4H3,(H,39,40)(H,41,42)(H,45,46)
|
Chemical Name |
(2R,2'R)-2,2'-((((5R,6R,7S,9S,11R,16R,18S,19S)-19-amino-11,16,18-trihydroxy-5,9-dimethylicosane-6,7-diyl)bis(oxy))bis(2-oxoethane-2,1-diyl))disuccinic acid
|
Synonyms |
HSDB 7077; RT013063; HSDB7077; RT-013063; HSDB-7077; RT 013063; Macrofusine
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
H2O : ~16.67 mg/mL (~23.09 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: 18.5 mg/mL (25.63 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with heating and sonication.
 (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 1.3854 mL | 6.9268 mL | 13.8537 mL | |
5 mM | 0.2771 mL | 1.3854 mL | 2.7707 mL | |
10 mM | 0.1385 mL | 0.6927 mL | 1.3854 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.